News | May 20, 2026
Zydus Lifesciences reports FY26 revenue of Rs. 27,148 crore, Q4 revenue up 16%
Company’s FY26 EBITDA rses 20% to Rs. 8,475 crore; Net profit grows 15% amid strong operational performance
Company’s FY26 EBITDA rses 20% to Rs. 8,475 crore; Net profit grows 15% amid strong operational performance
Sheshadri brings with him extensive leadership experience spanning healthcare, diagnostics, telecom, and consumer goods industries
The competition received over 42 entries from nursing colleges across Maharashtra
By leveraging digital screening and remote consultation, the medical community is moving beyond the confines of the clinic
In his new role, he will lead the growth strategy for the group’s operations, including Apothecon Pharmaceuticals in India and Navinta LLC in the United States
New CE-marked algorithm for the Azurion platform delivers improved image quality with over 50% lower radiation dose compared to the lowest settings on ClarityIQ
The drug is indicated for the maintenance treatment of patients with Chronic Obstructive Pulmonary Disease (COPD)
Combined footprint expands to 420 hearing care centres across India
The product has received tentative USFDA approval, Health Canada notice of compliance, and Indian regulatory approval
The development comes as stroke remains one of the world’s biggest health threats
Subscribe To Our Newsletter & Stay Updated
